ATR-IN-12

ATR-IN-12

• UNSPSC Description: ATR-IN-12 (Compound 5g) is a potent inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase with an IC50 value of 0.007 μM. ATR-IN-12 displays good anti-tumor activity and significantly reduces the phosphorylation level of ATR and its downstream signaling protein. ATR-IN-12 is a promising lead compound for subsequent agent discovery targeting ATR kinase[1].
• Target Antigen: ATM/ATR
• Type: Reference compound
• Related Pathways: Cell Cycle/DNA Damage;PI3K/Akt/mTOR
• Applications: Cancer-Kinase/protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/atr-in-12.html
• Solubility: 10 mM in DMSO
• Smiles: CC(S(=O)(N1CC2=NC(C3=CNC4=C3C=CC=C4)=NC(N5CCOC[C@H]5C)=C2C1)=O)C
• Molecular Weight: 441.55
• References & Citations: [1]Chen P, et al. Discovery of 6,7-dihydro-5H-pyrrolo[3,4-d] pyrimidine derivatives as a new class of ATR inhibitors. Bioorg Med Chem Lett. 2022;63:128651.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported